Purple sweet potato color inhibits endothelial premature senescence by blocking the NLRP3 inflammasome

Journal of Nutritional Biochemistry

Volumn 26, Issue 10, 2015, Pages 1029-1040

  Sun, Chunhui ^a   Fan, Shaohua ^a   Wang, Xin ^a   Lu, Jun ^a   Zhang, Zifeng ^a   Wu, Dongmei ^a   Shan, Qun ^a   Zheng, Yuanlin ^a  

^a JIANGSU NORMAL UNIVERSITY   (China)

Author keywords

Endothelial cells; NLRP3 inflammasome; Premature senescence; Purple sweet potato color; Type 2 diabetes mellitus

Indexed keywords

CRYOPYRIN; FLAVONOID; GALACTOSE; INFLAMMASOME; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; PIGMENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BIOACCUMULATION; CARDIOVASCULAR DISEASE; CELL AGING; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREMATURE AGING; SIGNAL TRANSDUCTION; SWEET POTATO; THORACIC AORTA; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; INSULIN RESISTANCE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ATHEROSCLEROSIS; CARRIER PROTEINS; CELL AGING; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; FLAVONOIDS; GALACTOSE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMASOMES; INSULIN RESISTANCE; IPOMOEA BATATAS; MALE; MICE; MICE, INBRED ICR; PIGMENTS, BIOLOGICAL; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84942553742     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.04.012     Document Type: Article

References (73)

1. Taguchi K., Matsumoto T., Kamata K., Kobayashi T. Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic mice. Pharmacol Res 2012, 65:56-65.
2. Massi-Benedetti M., Federici M.O. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia. Exp Clin Endocrinol Diabetes 1999, 107(Suppl. 4):S120-S123.
3. Schramm T.K., Gislason G.H., Kober L., Rasmussen S., Rasmussen J.N., Abildstrom S.Z., et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008, 117:1945-1954.
4. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
5. van den Oever I.A., Raterman H.G., Nurmohamed M.T., Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm 2010, 2010:792393. 10.1155/2010/792393.
6. O'Rourke M.F., Safar M.E., Dzau V. The cardiovascular continuum extended: aging effects on the aorta and microvasculature. Vasc Med 2010, 15:461-468.
7. Sawabe M. Vascular aging: from molecular mechanism to clinical significance. Geriatr Gerontol Int 2010, 10(Suppl. 1):S213-S220.
8. Behrendt D., Ganz P. Endothelial function. From vascular biology to clinical applications. Am J Cardiol 2002, 90:40L-48L.
9. Onat D., Brillon D., Colombo P.C., Schmidt A.M. Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Curr Diab Rep 2011, 11:193-202.
10. Minamino T., Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res 2007, 100:15-26.
11. Sun C., Liu X., Qi L., Xu J., Zhao J., Zhang Y., et al. Modulation of vascular endothelial cell senescence by integrin beta4. J Cell Physiol 2010, 225:673-681.
12. Loke W.M., Proudfoot J.M., Hodgson J.M., McKinley A.J., Hime N., Magat M., et al. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol 2010, 30:749-757.
13. Hagiwara A., Yoshino H., Ichihara T., Kawabe M., Tamano S., Aoki H., et al. Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine. J Toxicol Sci 2002, 27:57-68.
14. Kano M., Takayanagi T., Harada K., Makino K., Ishikawa F. Antioxidative activity of anthocyanins from purple sweet potato, Ipomoea batatas cultivar Ayamurasaki. Biosci Biotechnol Biochem 2005, 69:979-988.
15. Lu J., Wu D.M., Zheng Y.L., Hu B., Cheng W., Zhang Z.F. Purple sweet potato color attenuates domoic acid-induced cognitive deficits by promoting estrogen receptor-alpha-mediated mitochondrial biogenesis signaling in mice. Free Radic Biol Med 2012, 52:646-659.
16. Lu J., Wu D.M., Zheng Y.L., Hu B., Zhang Z.F. Purple sweet potato color alleviates d-galactose-induced brain aging in old mice by promoting survival of neurons via PI3K pathway and inhibiting cytochrome C-mediated apoptosis. Brain Pathol 2010, 20:598-612.
17. Shan Q., Lu J., Zheng Y., Li J., Zhou Z., Hu B., et al. Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by d-galactose. J Biomed Biotechnol 2009, 2009:564737. 10.1155/2009/564737.
18. Wang Y.J., Zheng Y.L., Lu J., Chen G.Q., Wang X.H., Feng J., et al. Purple sweet potato color suppresses lipopolysaccharide-induced acute inflammatory response in mouse brain. Neurochem Int 2010, 56:424-430.
19. Wu D.M., Lu J., Zheng Y.L., Zhou Z., Shan Q., Ma D.F. Purple sweet potato color repairs d-galactose-induced spatial learning and memory impairment by regulating the expression of synaptic proteins. Neurobiol Learn Mem 2008, 90:19-27.
20. Zhang Z.F., Fan S.H., Zheng Y.L., Lu J., Wu D.M., Shan Q., et al. Purple sweet potato color attenuates oxidative stress and inflammatory response induced by d-galactose in mouse liver. Food Chem Toxicol 2009, 47:496-501.
21. Zhang Z.F., Lu J., Zheng Y.L., Hu B., Fan S.H., Wu D.M., et al. Purple sweet potato color protects mouse liver against d-galactose-induced apoptosis via inhibiting caspase-3 activation and enhancing PI3K/Akt pathway. Food Chem Toxicol 2010, 48:2500-2507.
22. Zhang Z.F., Lu J., Zheng Y.L., Wu D.M., Hu B., Shan Q., et al. Purple sweet potato color attenuates hepatic insulin resistance via blocking oxidative stress and endoplasmic reticulum stress in high-fat-diet-treated mice. J Nutr Biochem 2013, 24:1008-1018.
23. Franceschi C., Valensin S., Bonafe M., Paolisso G., Yashin A.I., Monti D., et al. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol 2000, 35:879-896.
24. Lamkanfi M., Dixit V.M. Inflammasomes: guardians of cytosolic sanctity. Immunol Rev 2009, 227:95-105.
25. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10:417-426.
26. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011, 11:213-220.
27. Youm Y.H., Kanneganti T.D., Vandanmagsar B., Zhu X., Ravussin A., Adijiang A., et al. The Nlrp3 inflammasome promotes age-related thymic demise and immunosenescence. Cell Reprogram 2012, 1:56-68.
28. Zhang L., Zhao J., Su L., Huang B., Wang L., Su H., et al. D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein e-/- mice: a role of phosphatidylcholine-specific phospholipase in atherosclerosis. Arterioscler Thromb Vasc Biol 2010, 30:411-418.
29. Babcock G.F. Quantitation of phagocytosis by confocal microscopy. Methods Enzymol 1999, 307:319-328.
30. Hayashi T., Yamaguchi T., Sakakibara Y., Taguchi K., Maeda M., Kuzuya M., et al. eNOS-dependent antisenscence effect of a calcium channel blocker in human endothelial cells. PLoS One 2014, 9:e88391. 10.1371/journal.pone.0088391.
31. Zhao X.Y., Sun J.L., Hu Y.J., Yang Y., Zhang W.J., Hu Y., et al. The effect of overexpression of PGC-1alpha on the mtDNA4834 common deletion in a rat cochlear marginal cell senescence model. Hear Res 2013, 296:13-24.
32. Konishi Y., Stegmuller J., Matsuda T., Bonni S., Bonni A. Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science 2004, 303:1026-1030.
33. Debacq-Chainiaux F., Erusalimsky J.D., Campisi J., Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009, 4:1798-1806.
34. Lu J., Wu D.M., Zheng Z.H., Zheng Y.L., Hu B., Zhang Z.F. Troxerutin protects against high cholesterol-induced cognitive deficits in mice. Brain 2011, 134:783-797.
35. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation 1995, 92:657-671.
36. Kashio A., Amano A., Kondo Y., Sakamoto T., Iwamura H., Suzuki M., et al. Effect of vitamin C depletion on age-related hearing loss in SMP30/GNL knockout mice. Biochem Biophys Res Commun 2009, 390:394-398.
37. Kondo Y., Sasaki T., Sato Y., Amano A., Aizawa S., Iwama M., et al. Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice. Biochem Biophys Res Commun 2008, 377:291-296.
38. Yamada S., Saitoh S., Machii H., Mizukami H., Hoshino Y., Misaka T., et al. Coronary artery spasm related to thiol oxidation and senescence marker protein-30 in aging. Antioxid Redox Signal 2013, 19:1063-1073.
39. Maruyama N., Ishigami A., Kondo Y. Pathophysiological significance of senescence marker protein-30. Geriatr Gerontol Int 2010, 10(Suppl. 1):S88-S98.
40. Medina R.J., O'Neill C.L., O'Doherty T.M., Chambers S.E., Guduric-Fuchs J., Neisen J., et al. Ex vivo expansion of human outgrowth endothelial cells leads to IL-8-mediated replicative senescence and impaired vasoreparative function. Stem Cells 2013, 31:1657-1668.
41. Haendeler J., Hoffmann J., Diehl J.F., Vasa M., Spyridopoulos I., Zeiher A.M., et al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004, 94:768-775.
42. Passos J.F., von Zglinicki T. Mitochondria, telomeres and cell senescence. Exp Gerontol 2005, 40:466-472.
43. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000, 49:1939-1945.
44. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010, 11:136-140.
45. De Nardo D., Latz E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 2011, 32:373-379.
46. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440:228-232.
47. Kirpichnikov D., Sowers J.R. Diabetes mellitus and diabetes-associated vascular disease. Trends Endocrinol Metab 2001, 12:225-230.
48. Orasanu G., Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009, 53:S35-S42.
49. Lu F.P., Lin K.P., Kuo H.K. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 2009, 4:e4144. 10.1371/journal.pone.0004144.
50. Yokoi T., Fukuo K., Yasuda O., Hotta M., Miyazaki J., Takemura Y., et al. Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells. Diabetes 2006, 55:1660-1665.
51. Kohen Avramoglu R., Laplante M.A., Le Quang K., Deshaies Y., Despres J.P., Larose E., et al. The genetic and metabolic determinants of cardiovascular complications in type 2 diabetes: recent insights from animal models and clinical investigations. Can J Diabetes 2013, 37:351-358.
52. Paigen B. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 1995, 62:458S-462S.
53. Liu J., Zhou L., Xiong K., Godlewski G., Mukhopadhyay B., Tam J., et al. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology 2012, 142:1218-1228.
54. Yoshino J., Mills K.F., Yoon M.J., Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 2011, 14:528-536.
55. Miyazaki K., Makino K., Iwadate E., Deguchi Y., Ishikawa F. Anthocyanins from purple sweet potato Ipomoea batatas cultivar Ayamurasaki suppress the development of atherosclerotic lesions and both enhancements of oxidative stress and soluble vascular cell adhesion molecule-1 in apolipoprotein E-deficient mice. J Agric Food Chem 2008, 56:11485-11492.
56. Park K.H., Kim J.R., Lee J.S., Lee H., Cho K.H. Ethanol and water extract of purple sweet potato exhibits anti-atherosclerotic activity and inhibits protein glycation. J Med Food 2010, 13:91-98.
57. Cui X., Wang L., Zuo P., Han Z., Fang Z., Li W., et al. d-Galactose-caused life shortening in Drosophila melanogaster and Musca domestica is associated with oxidative stress. Biogerontology 2004, 5:317-325.
58. 2. Basic Clin Pharmacol Toxicol 2007, 101:447-454.
59. Campisi J. Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev 2011, 21:107-112.
60. Olivieri F., Lazzarini R., Recchioni R., Marcheselli F., Rippo M.R., Di Nuzzo S., et al. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr) 2013, 35:1157-1172.
61. Wen H., Ting J.P., O'Neill L.A. A role for the NLRP3 inflammasome in metabolic diseases - did Warburg miss inflammation?. Nat Immunol 2012, 13:352-357.
62. Shimabukuro M., Hirata Y., Tabata M., Dagvasumberel M., Sato H., Kurobe H., et al. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2013, 33:1077-1084.
63. Xiao H., Lu M., Lin T.Y., Chen Z., Chen G., Wang W.C., et al. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation 2013, 128:632-642.
64. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
65. Dixit V.D. Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?. Diabetes 2013, 62:22-24.
66. Lee H.M., Kim J.J., Kim H.J., Shong M., Ku B.J., Jo E.K. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes 2013, 62:194-204.
67. Labus J., Hackel S., Lucka L., Danker K. Interleukin-1beta induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model. J Neurosci Methods 2014, 228:35-45.
68. Liu X., Ye F., Xiong H., Hu D., Limb G.A., Xie T., et al. IL-1beta upregulates IL-8 production in human Muller cells through activation of the p38 MAPK and ERK1/2 signaling pathways. Inflammation 2014, 37:1486-1495.
69. Korybalska K., Kawka E., Kusch A., Aregger F., Dragun D., Jorres A., et al. Recovery of senescent endothelial cells from injury. J Gerontol A Biol Sci Med Sci 2013, 68:250-257.
70. Murohara T., Witzenbichler B., Spyridopoulos I., Asahara T., Ding B., Sullivan A., et al. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 1999, 19:1156-1161.
71. Hayashi T., Matsui-Hirai H., Miyazaki-Akita A., Fukatsu A., Funami J., Ding Q.F., et al. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci U S A 2006, 103:17018-17023.
72. Thomas S.R., Witting P.K., Drummond G.R. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 2008, 10:1713-1765.
73. Bornfeldt K.E., Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 2011, 14:575-585.